26 filings · most recent first
EW 8-K Filings
Edwards Lifesciences Reports Q2 2026 Financial Results And Updates Guidance
Edwards Lifesciences Approves Amended Longterm Stock Incentive Compensation
Edwards Lifesciences Appoints Theodora Mistras As New Cfo
Edwards Lifesciences Reports Strong Q1 2026 Financial Results And Raises
Edwards Lifesciences Reports Strong Q4 And Fullyear 2025 Results
Edwards Lifesciences Acquisition Blocked By Injunction
Edwards Lifesciences Announces Cfo Transition Plan
Edwards Lifesciences Announces Corporate Vice President Resignation
Edwards Lifesciences To Sell Critical Care To Bd For 42 Billion
Edwards Lifesciences Reports Strong Third Quarter Financial Results
Edwards Lifesciences Announces Accelerated Share Repurchase Agreement
Edwards Lifesciences Announces Ftc Move To Block Jenavalve Acquisition
Edwards Lifesciences Reports Strong Q2 Results With 119 Sales Growth And
Edwards Lifesciences Announces Stockholder Approvals And Officer Appointments
Edwards Lifesciences Reports Strong Q1 2025 Results
Edwards Lifesciences Reports 9 Sales Growth In Q4 2024 With Earnings Beat
Edwards Lifesciences Reports Q3 2024 Financial Results
Edwards Lifesciences Announces Sale Of Critical Care Product Group And Share
Edwards Lifesciences Announces Q2 2024 Results And Acquisitions
Edwards Lifesciences Announces Acquisition Of Innovalve
Edwards Lifesciences Appoints Dr David T Feinberg To Board
Edwards Lifesciences Announces Retirement Of Principal Accounting Officer
Edwards Lifesciences Corporation Announces Voting Results From Annual Meeting
Edwards Lifesciences Reports Q1 2024 Financial Results And Raises Guidance
Edwards Lifesciences Announces Leadership Changes
Edwards Lifesciences Reports Fourth Quarter 2023 Financial Results